Smith Pharma
ActiveSummary
Smith Pharma has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €146,292 and a net result of €56,410. Equity is growing by about 9.2% per year across the filed financial years. Its solvency ranks better than 35% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 20 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 12342C0227/00E003 | Flanders | 139 m² | 1 · 139 m² | 10.3 m · 2 |